SMTL ID : 5nun.1

Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

homo-dimer

Ligands

2 x Z80: 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine(Non-covalent)

Z80.1: 10 residues within 4Å: Chain A: P.38, A.39, V.41, I.56, L.58, I.71, N.90, F.107, E.108, S.116 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:V.41, A:V.41, A:I.71 pi-Stacking: A:F.107 Z80.2: 10 residues within 4Å: Chain B: P.38, A.39, V.41, I.56, L.58, I.71, N.90, F.107, E.108, S.116 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:V.41, B:V.41, B:I.71 pi-Stacking: B:F.107

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Loch, J.I. et al., The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol. (2018)

Release Date

2018-04-04

Peptides

Beta-lactoglobulin: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Beta-lactoglobulin